Homburger advises international debt funds on financing process
Homburger advised multiple international debt funds as arrangers and original lenders in financing Athagoras Group’s acquisition of CSO Pharma Consulting and MIGx.
Buying and selling parties
Athagoras is a technology-enabled platform for life sciences that helps pharma, biotech and medtech companies achieving fast and efficient access to their core markets. Its services spans regulatory affair and pharmacovigilance matters. The company is part of a larger portfolio held by Greenpeak , a Dutch “buy and build” firm specialised in developing platforms for sustainable growth.
CSO advises pharmaceutical companies and healthcare providers across a plethora of sectors, including pharmacovigilance, medical affairs, quality management & GDP and development consulting. Its customers have full-access to an audited pharmacovigilance system, which functionally positions the company as a dedicated outsourcing partner.
MigX ‘s expertise as life-science service provider lies in the areas of data integration and AI. Once a small tech startup, the company has been substantially growing its operative reach over the past few years.
The team
Homburger covered all Swiss legal aspects of the financing transactions on behalf of the international debt funds involved. Partner Jürg Frick (financing and investment products, pictured) led the team, with further support from partner Stefan Oesterhelt (tax) and junior associate Riccardo Pompeo (financing and investment products).
